Inflammatory mediators and lung function in older COVID-19 survivors.

Cataneo,D.,Chavez-Galan,L.,Mondragon-Posadas,L.,Sanchez-Garrido,N.,Buendia- Roldan,I.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa5315

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Background: Severe COVID-19 in older adults is associated with multisystemic inflammation, leading to poor outcomes. The long-term consequences and how subacute inflammation affects pulmonary function remain unclear. Aim: to analyze the relationship between inflammatory cytokines four months after discharge and lung function one year later in severe COVID-19 older survivors, and the influence of steroid use in their performance. Methods: Twenty patients, predominantly female, were recruited from a specialized Post-COVID Care Clinic. Blood samples were collected four months after discharge, and flow cytometry was performed to measure intracellular cytokines in CD4+ T-cells. Pulmonary function tests were conducted one-year post-discharge. A Pearson correlation was done to assess the relationship between cytokine levels and pulmonary function. Results: At the four-month assessment, it was observed that patients exhibiting CD4+ T cells expressing IFN- (rho –0.673, p=0.008), IL-10 (rho –0.705, p=0.007), and IL-4 (rho –0.716, p=0.013) displayed a negative correlation with DLCO levels at the one-year follow-up. Conclusions: There is a statistically significant correlation between intracellular cytokines and reduced pulmonary function, particularly DLCO, at the one-year mark. Detection of inflammatory mediators four months after discharge from critical illness can help anticipate long-term pulmonary impairment in older survivors. Fig 1. Inverse correlation between four-months intracellular cytokines and one-year pulmonary function test in older adults who survived COVID-19

respiratory system